Literature DB >> 308317

Venous catheter-associated candidemia.

H D Rose.   

Abstract

Fifty-five patients with venous catheter-associated candidemia were seen over a 13-year period. Thirty-five patients recovered from the infection. Twenty-six of these patients became afebrile within 72 hours of catheter removal; none were treated with systemic antifungal agents. Endophthalmitis appeared in four patients, three of whom had significant loss of vision. Nine patients had persistent candidemia following catheter removal and required antifungal therapy; none developed metastatic infection. Twenty other critically ill patients died during fungemia. Two of these patients were found to have Candida endocarditis that arose from previous catheter infections not suspected of being caused by this organism. Prevention of candidemia by proper care of indwelling vascular catheters is the ultimate goal. Appropriate management of the episodes of candidemia that occur may avert serious metastatic complications.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308317     DOI: 10.1097/00000441-197805000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  12 in total

1.  Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.

Authors:  P Phillips; S Shafran; G Garber; C Rotstein; F Smaill; I Fong; I Salit; M Miller; K Williams; J M Conly; J Singer; S Ioannou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

2.  Nonvalue of antigen detection immunoassays for diagnosis of candidemia.

Authors:  P Phillips; A Dowd; P Jewesson; G Radigan; M G Tweeddale; A Clarke; I Geere; M Kelly
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 3.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Torulopsis candida, a new opportunistic pathogen.

Authors:  G St-Germain; M Laverdière
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

Review 6.  Candida infection in surgical patients.

Authors:  J S Solomkin; R L Simmons
Journal:  World J Surg       Date:  1980-07       Impact factor: 3.352

7.  Intravenous catheter-associated fungemia due to Candida rugosa.

Authors:  J F Reinhardt; P J Ruane; L J Walker; W L George
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

Authors:  J S Solomkin; A Flohr; R L Simmons
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

9.  Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.

Authors:  V Fainstein; G P Bodey; L Elting; A Maksymiuk; M Keating; K B McCredie
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

Review 10.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.